Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 9/20 | 0.51 |
| ▸ | TSHR | P16473 | 2/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.51 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.42 |
| ▸ | MEN1 | O00255 | 3/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | HTT | P42858 | 1/20 | 0.41 |
| ▸ | PKM | P14618 | 1/20 | 0.41 |
| ▸ | GBA1 | P04062 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5377178 | 0.90 | KDM4E (0.47) | KDM4ETSHRALDH1A1TDP1KMT2A | |
| SCHEMBL18586975 | 0.90 | KDM4E (0.47) | KDM4ETSHRALDH1A1TDP1KMT2A | |
| SCHEMBL12964150 | 0.85 | KDM4E (0.43) | KDM4ETSHRALDH1A1TDP1KMT2A | |
| SCHEMBL29738712 | 0.85 | KDM4E (0.44) | KDM4ETSHRALDH1A1TDP1KMT2A | |
| SCHEMBL21525758 | 0.85 | KDM4E (0.44) | KDM4ETSHRALDH1A1TDP1KMT2A | |
| SCHEMBL9112636 | 0.85 | ALDH1A1 (0.40) | KDM4ETSHRALDH1A1TDP1KMT2A | |
| SCHEMBL12191679 | 0.81 | KDM4E (0.46) | KDM4ETSHRALDH1A1TDP1KMT2A | |
| SCHEMBL145617 | 0.81 | KDM4E (0.49) | KDM4ETSHRALDH1A1TDP1KMT2A | |
| SCHEMBL12512715 | 0.81 | KDM4E (0.42) | KDM4ETSHRALDH1A1TDP1KMT2A | |
| SCHEMBL15367747 | 0.81 | KDM4E (0.42) | KDM4ETSHRALDH1A1TDP1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1363 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2970522-B1 | IN-MOLD COATING OF ROMP POLYMERS | MATERIA INC (US) | 2025-05-21 | — | — | EP | claimed |
| EP-4504803-A1 | PALLADIUM CATALYSTS FOR FORMING VINYL ADDITION POLYMERS HAVING IMPROVED FILM FORMING PROPERTIES | Promerus, LLC (US) | 2025-02-12 | — | — | EP | claimed |
| CN-119137161-A | Palladium catalyst for vinyl addition polymer formation with improved film forming properties | 普罗米鲁斯有限责任公司 | 2024-12-13 | — | — | CN | claimed |
| CN-119101214-A | Cycloolefin metathesis composition and polymerization method thereof | 道生天合材料科技(上海)股份有限公司 | 2024-12-10 | — | — | CN | claimed |
| US-12043573-B2 | Adhesion promoters and gel-modifiers for olefin metathesis compositions | MATERIA, INC. (US) | 2024-07-23 | — | — | US | claimed |
| US-20240043608-A1 | METHOD AND COMPOSITION FOR IMPROVING ADHESION OF METATHESIS COMPOSITIONS TO SUBSTRATES | MATERIA, INC. (US) | 2024-02-08 | — | — | US | claimed |
| EP-3053954-B1 | MODIFIED OLEFIN RESIN | LG CHEMICAL LTD (KR) | 2023-12-06 | — | — | EP | claimed |
| EP-3256505-B1 | CYCLIC OLEFIN RESIN COMPOSITIONS COMPRISING FUNCTIONAL ELASTOMERS | MATERIA INC (US) | 2023-11-29 | — | — | EP | claimed |
| WO-2023196366-A1 | PALLADIUM CATALYSTS FOR FORMING VINYL ADDITION POLYMERS HAVING IMPROVED FILM FORMING PROPERTIES | PROMERUS, LLC (US) | 2023-10-12 | — | — | WO | claimed |
| US-20230312775-A1 | PALLADIUM CATALYSTS FOR FORMING VINYL ADDITION POLYMERS HAVING IMPROVED FILM FORMING PROPERTIES | PROMERUS, LLC (US) | 2023-10-05 | — | — | US | claimed |
| US-20160046657-A1 | ORGANOPALLADIUM COMPOUNDS AS POLYMERIZATION CATALYSTS | SUMITOMO BAKELITE CO., LTD. (JP) | 2016-02-18 | — | — | US | claimed |
| EP-2721106-A2 | ADHESION PROMOTERS AND GEL-MODIFIERS FOR OLEFIN METATHESIS COMPOSITIONS | Materia, Inc. (US) | 2014-04-23 | — | — | EP | claimed |
| WO-2012174502-A2 | ADHESION PROMOTERS AND GEL-MODIFIERS FOR OLEFIN METATHESIS COMPOSITIONS | MATERIA, INC. (US) | 2012-12-20 | — | — | WO | claimed |
| US-6811846-B1 | THREE- OR FIVE-LAYERED LAMINATED PLASTIC MOLDED BODY HAVING POLYETHYLENE TEREPHTHALATE LAYERS LAMINATED ALTERNATELY WITH POLYOLEFIN RESIN LAYERS HAVING CYCLIC OLEFIN COMPONENT; TRANSPARENT, OIL RESISTANT, VAPOR BARRIER PROPERTIES | YOSHINO KOGYOSHO CO., LTD. (JP) | 2004-11-02 | — | — | US | claimed |
| US-6627714-B2 | Copolymerizing ethylene and dicyclopentadiene or tricyclopentadiene, and cyclic olefin in presence of metallocene catalyst to produce copolymer | MARUZEN PETROCHEMICAL CO., LTD. (JP) | 2003-09-30 | — | — | US | claimed |
| US-6451946-B1 | Copolymer, process for the production thereof, and molded article thereof | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2002-09-17 | — | — | US | claimed |
| EP-0997141-A1 | COSMETIC COMPOSITION CONTAINING AT LEAST ONE AMORPHOUS POLYCYCLOOLEFINE OR A MIXTURE AND THEIR USE | L'OREAL (FR) | 2000-05-03 | — | — | EP | claimed |
| EP-0446051-B1 | Process for the production of cycloolefin-based random copolymer | MITSUI PETROCHEMICAL IND (JP) | 1995-11-15 | — | — | EP | claimed |
| US-5142007-A | Copolymerizing with ethylene and at least one unsaturated monomer in presence of catalysts and mixed solvent | MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) | 1992-08-25 | — | — | US | claimed |
| EP-0446051-A1 | Process for the production of cycloolefin-based random copolymer | MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) | 1991-09-11 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160046657-A1 | ORGANOPALLADIUM COMPOUNDS AS POLYMERIZATION CATALYSTS | MVD, DDT, CDV3 | KDM4E 1705/4885TSHR 4854/4885ALDH1A1 1284/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.